DOTS Technology
Dr. André Cheng brings over 25 years of healthcare experience as a physician, industry executive, and investor. He is Partner and Portfolio Manager at Granite Point Capital, where he leads the Panacea global healthcare fund. Dr. Cheng was previously the Worldwide VP of Health Economics & Reimbursement for J&J Ethicon subsequent to its acquisition of his prior startup company Acclarent. He was on the management team at The Advisory Board Company during its transition from a private to public company and has led multiple business units focused on medical technology assessment. Dr. Cheng holds an M.D. from Johns Hopkins School of Medicine, a Ph.D. from Johns Hopkins School of Public Health, and an A.B. in Biochemical Sciences from Harvard College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
DOTS Technology
DOTS (Detection On the Spot) has a mission to make people’s lives better through a disruptive diagnostics platform that gives them information to make better decisions.